Profil
Oliver Bielenstein is currently the Co-Managing Director at botiss medical AG and Botiss Biomaterials GmbH.
Previously, he worked as the Chief Financial Officer at aap Implantate AG from 2004 to 2008.
Aktive Positionen von Oliver Bielenstein
Unternehmen | Position | Beginn |
---|---|---|
botiss medical AG
botiss medical AG BiotechnologyHealth Technology botiss medical AG engages in the development, production, and distribution of medical instruments and supplies. The company was founded in 2008 and is headquartered in Berlin, Germany. | Vorstandsvorsitzender | - |
Botiss Biomaterials GmbH
Botiss Biomaterials GmbH Medical SpecialtiesHealth Technology Botiss Biomaterials GmbH specializes in bone and soft tissue regeneration. The private company is based in Zossen, Germany and was founded in 2009. The CEOs are Oliver Bielenstein and Drazen Tadic. Botiss Biomaterials is committed to developing innovative products and a holistic 360° system in collaboration with international experts. The German company prioritizes the safety and reliability of its products and is dedicated to constant innovation and education. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Oliver Bielenstein
Unternehmen | Position | Ende |
---|---|---|
AAP IMPLANTATE AG | Finanzdirektor/CFO | 31.12.2008 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AAP IMPLANTATE AG | Health Technology |
Private Unternehmen | 2 |
---|---|
botiss medical AG
botiss medical AG BiotechnologyHealth Technology botiss medical AG engages in the development, production, and distribution of medical instruments and supplies. The company was founded in 2008 and is headquartered in Berlin, Germany. | Health Technology |
Botiss Biomaterials GmbH
Botiss Biomaterials GmbH Medical SpecialtiesHealth Technology Botiss Biomaterials GmbH specializes in bone and soft tissue regeneration. The private company is based in Zossen, Germany and was founded in 2009. The CEOs are Oliver Bielenstein and Drazen Tadic. Botiss Biomaterials is committed to developing innovative products and a holistic 360° system in collaboration with international experts. The German company prioritizes the safety and reliability of its products and is dedicated to constant innovation and education. | Health Technology |